Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.460
-0.050 (-3.31%)
Jun 29, 2026, 1:08 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 174.06 million as of June 29, 2026. Its market cap has increased by 8.00% in one year.
Market Cap
174.06M
Enterprise Value
146.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.46
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 174.06M, an increase of 84.55%. That is a compound annual growth rate of 8.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 174.06M | 33.52% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 290.99M |
| Auxly Cannabis Group | 265.21M |
| Aurora Cannabis | 250.87M |
| Organigram Global | 205.53M |
| Cannara Biotech | 165.95M |
| BioSyent | 160.71M |
| Ascend Wellness Holdings | 143.99M |
| Grown Rogue International | 142.47M |